Tony Mok, MD, on Oncogene-Addicted NSCLC: Expert Perspective on the Challenges

Posted: Monday, September 11, 2017

Tony Mok, MD, of the Chinese University of Hong Kong, discusses new drivers in this disease setting as well as strategies against mechanisms of resistance and the role of immunotherapy.